Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilhelm Krek

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nature Cell Biology|November 1, 2003
BTB proteins as henchmen of Cul3-based ubiquitin ligasesWilhelm Krek
Physiology (Bethesda, Md.)|November 23, 2006
SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiologyDimitrios Anastasiou, Wilhelm Krek
Oncotarget|April 1, 2015
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancerYann Christinat, Wilhelm Krek
Biochimica Et Biophysica Acta|February 21, 2016
Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart diseasePeter Mirtschink, Wilhelm Krek
Trends in Molecular Medicine|September 8, 2004
The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesisRobert E Barry, Wilhelm Krek
Current Opinion in Cell Biology|November 17, 2007
Multitasking by pVHL in tumour suppressionIan J Frew, Wilhelm Krek
Science Signaling|June 19, 2008
pVHL: a multipurpose adaptor proteinIan J Frew, Wilhelm Krek
Bioinformatics (Oxford, England)|May 7, 2016
jSplice: a high-performance method for accurate prediction of alternative splicing events and its application to large-scale renal cancer transcriptome dataYann Christinat, Rafał Pawłowski, Wilhelm Krek
Cell Cycle (Georgetown, Tex.)|August 3, 2007
The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenanceClaudio R Thoma, Ian J Frew, Wilhelm Krek
Cancer Informatics|May 24, 2012
Identification of a gene expression signature common to distinct cancer pathwaysNiklaus Fankhauser, Igor Cima, Peter Wild, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nature Cell Biology|November 1, 2003
BTB proteins as henchmen of Cul3-based ubiquitin ligasesWilhelm Krek
Physiology (Bethesda, Md.)|November 23, 2006
SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiologyDimitrios Anastasiou, Wilhelm Krek
Oncotarget|April 1, 2015
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancerYann Christinat, Wilhelm Krek
Biochimica Et Biophysica Acta|February 21, 2016
Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart diseasePeter Mirtschink, Wilhelm Krek
Trends in Molecular Medicine|September 8, 2004
The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesisRobert E Barry, Wilhelm Krek
Current Opinion in Cell Biology|November 17, 2007
Multitasking by pVHL in tumour suppressionIan J Frew, Wilhelm Krek
Science Signaling|June 19, 2008
pVHL: a multipurpose adaptor proteinIan J Frew, Wilhelm Krek
Bioinformatics (Oxford, England)|May 7, 2016
jSplice: a high-performance method for accurate prediction of alternative splicing events and its application to large-scale renal cancer transcriptome dataYann Christinat, Rafał Pawłowski, Wilhelm Krek
Cell Cycle (Georgetown, Tex.)|August 3, 2007
The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenanceClaudio R Thoma, Ian J Frew, Wilhelm Krek
Cancer Informatics|May 24, 2012
Identification of a gene expression signature common to distinct cancer pathwaysNiklaus Fankhauser, Igor Cima, Peter Wild, et al.
Pageof 7